Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4089317
Max Phase: Preclinical
Molecular Formula: C30H39NO5
Molecular Weight: 493.64
Molecule Type: Small molecule
Associated Items:
ID: ALA4089317
Max Phase: Preclinical
Molecular Formula: C30H39NO5
Molecular Weight: 493.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(NC(=O)c2ccc(O)c(O)c2CC=C(C)C)c(C/C=C(\C)CCC=C(C)C)c(OC)c1
Standard InChI: InChI=1S/C30H39NO5/c1-19(2)9-8-10-21(5)12-14-25-26(17-22(35-6)18-28(25)36-7)31-30(34)24-15-16-27(32)29(33)23(24)13-11-20(3)4/h9,11-12,15-18,32-33H,8,10,13-14H2,1-7H3,(H,31,34)/b21-12+
Standard InChI Key: AEPSHCLPPWIKID-CIAFOILYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 493.64 | Molecular Weight (Monoisotopic): 493.2828 | AlogP: 7.11 | #Rotatable Bonds: 11 |
Polar Surface Area: 88.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.40 | CX Basic pKa: | CX LogP: 7.26 | CX LogD: 7.22 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.23 | Np Likeness Score: 0.88 |
1. Stockdale DP, Titunick MB, Biegler JM, Reed JL, Hartung AM, Wiemer DF, McLaughlin PJ, Neighbors JD.. (2017) Selective opioid growth factor receptor antagonists based on a stilbene isostere., 25 (16): [PMID:28693915] [10.1016/j.bmc.2017.06.035] |
Source(1):